Identification of peptides and other organic substances to inhibit the virus-host cell-interaction
The new technology stands at an early stage of development (lab level). The inventors developed a method for identification of short coiled-coil sequences which are binding the viral envelope protein. The coiled-coil interaction is basic to the fusion of virus membrane with the target membrane. The identification of high specific, short peptides which can inhibit the virus-host cell interaction without induction of an immune response could lead to the development of new antiviral pharmaceuticals. The inventors developed a method of identification using SPOT-Technology on cellulose membranes. Investigation on HA2 virus (Influenza) and Tuberculosis are in process, studies on HIV, SIV, Ebola should follow.
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Ursula Haufe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Economies take off with new airports
A global study by an SUTD researcher in collaboration with scientists from Japan explores the economic benefits of airport investment in emerging economies using nighttime satellite imagery. Be it for…
CAR T–cell immunotherapy targets
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets. Scientists at St. Jude Children’s Research Hospital found 156 potential CAR targets across the brain and solid tumors,…
Stony coral tissue loss disease
… is shifting the ecological balance of Caribbean reefs. The outbreak of a deadly disease called stony coral tissue loss disease is destroying susceptible species of coral in the Caribbean…
